Medicofarma Biotech SA (WSE:MDB)
Poland · Delayed Price · Currency is PLN 0.4690
-0.0080 (-1.68%)
At close: Mar 5, 2026
Medicofarma Biotech Market Cap
Medicofarma Biotech has a market cap or net worth of 32.22 million as of March 6, 2026. Its market cap has increased by 42.77% in one year.
Market Cap
32.22M
Enterprise Value
35.51M
Revenue
281.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.47
Market Cap Chart
Since January 30, 2009, Medicofarma Biotech's market cap has increased from 6.50M to 32.22M, an increase of 395.72%. That is a compound annual growth rate of 9.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 31.88M | 17.54% |
| Dec 30, 2025 | 27.12M | 2.84% |
| Dec 30, 2024 | 26.38M | -64.24% |
| Dec 29, 2023 | 73.76M | -6.06% |
| Dec 30, 2022 | 78.51M | -32.05% |
| Dec 30, 2021 | 115.54M | 483.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.07B |
| NEUCA | 3.33B |
| Synektik Spólka Akcyjna | 2.45B |
| Voxel | 1.35B |
| BioMaxima | 50.53M |
| Sygnis | 42.51M |
| Pharmena | 34.53M |
| Pure Biologics | 30.59M |